| Literature DB >> 23070159 |
A M Healan1, W Gray, E J Fuchs, J M Griffiss, R A Salata, J Blumer.
Abstract
Colistimethate sodium, increasingly used to treat multidrug-resistant Gram-negative infections, spontaneously hydrolyzes to form colistin A (polymyxin E1) and B (polymyxin E2/B) when mixed with water. High levels of these active breakdown products at the time of administration have been associated with nephrotoxicity and even death. In this study, reconstituted colistimethate sodium was shown to be stable (<1.0% colistin A/B formation) for up to 24 h when stored at 21, 0, -20, and -70°C.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23070159 PMCID: PMC3497204 DOI: 10.1128/AAC.01079-12
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191